Display options
Share it on

Infection. 1979;7(3):129-45. doi: 10.1007/BF01641314.

[Tissue penetration of erythromycin (author's transl)].

Infection

[Article in German]
G A Dette

PMID: 478653 DOI: 10.1007/BF01641314

Abstract

Although erythromycin has been used in therapy for more than 25 years, until now there has been no paper summarizing the data on tissue penetration. The present review documents in detail dose- and time-related peak serum levels of erythromycin derivatives after oral administration, in addition to the erythromycin tissue levels. The erythromycin tissue levels often manifoldly exceed the corresponding MIC values of pathogens sensitive to erythromycin. However, erythromycin does not penetrate the central nervous system, or only penetrates in small, incalculable amounts. The same applies for the placental passage of erythromycin. The tissue levels confirm, with respect to the MIC values of the pathogen spectrum, clinical experience with erythromycin in the treatment of ear, nose and throat infections, respiratory tract infections and, with some limitations Chlamydia urethritis.

References

  1. Z Geburtshilfe Gynakol. 1964 Apr;162:36-45 - PubMed
  2. Am J Med Sci. 1965 Sep;250(3):261-8 - PubMed
  3. Antibiot Chemother (Northfield). 1954 Sep;4(9):926-30 - PubMed
  4. Antibiot Chemother (Northfield). 1953 Sep;3(9):930-2 - PubMed
  5. Ter Arkh. 1964 May;36:40-4 - PubMed
  6. Ann Inst Pasteur (Paris). 1957 Jun;92(6):760-77 - PubMed
  7. Br Med J. 1978 Aug 19;2(6136):536-7 - PubMed
  8. Arch Ophthalmol. 1977 Jun;95(6):1065-7 - PubMed
  9. Antibiot Annu. 1958-1959;6:211-20 - PubMed
  10. Am J Clin Pathol. 1957 Feb;27(2):159-69 - PubMed
  11. J Pharm Sci. 1972 Mar;61(3):425-8 - PubMed
  12. J Clin Pharmacol. 1978 Apr;18(4):194-202 - PubMed
  13. Antibiot Annu. 1958-1959;6:375-81 - PubMed
  14. J Am Pharm Assoc Am Pharm Assoc. 1952 Oct;41(10):555-9 - PubMed
  15. Antimicrob Agents Chemother (Bethesda). 1965;5:1051-7 - PubMed
  16. Am J Ophthalmol. 1964 Sep;58:443-7 - PubMed
  17. Boll Mal Orecch Gola Naso. 1965 Sep-Oct;83(5):606-17 - PubMed
  18. Am J Med Sci. 1964 Jan;247:69-74 - PubMed
  19. Clin Pediatr (Phila). 1976 May;15(5):428-31 - PubMed
  20. Arzneimittelforschung. 1975 Nov;25(11):1828-31 - PubMed
  21. Antibiot Chemother (Northfield). 1953 May;3(5):473-7 - PubMed
  22. J Pharm Sci. 1978 Aug;67(8):1057-9 - PubMed
  23. Proc Staff Meet Mayo Clin. 1952 Jul 16;27(15):285-304 - PubMed
  24. Antibiot Annu. 1957-1958;5:350-64 - PubMed
  25. Am J Obstet Gynecol. 1955 Jan;69(1):174-7 - PubMed
  26. Ergeb Mikrobiol Immunitatsforsch Exp Ther. 1960;33:307-68 - PubMed
  27. Curr Med Res Opin. 1976;4(5):359-64 - PubMed
  28. Antibiotic Med Clin Ther (New York). 1959 Jun;6(6):347-52 - PubMed
  29. Acta Pharmacol Toxicol (Copenh). 1959;16:194-200 - PubMed
  30. J Pediatr. 1965 Jun;66:1068-82 - PubMed
  31. Scand J Infect Dis. 1975;7(3):209-17 - PubMed
  32. Antimicrob Agents Chemother. 1974 Jul;6(1):114-5 - PubMed
  33. Scott Med J. 1977 Dec;22(5):355-9 - PubMed
  34. Nature. 1968 Jul 13;219(5150):139-43 - PubMed
  35. Am J Dis Child. 1969 Mar;117(3):276-80 - PubMed
  36. Antimicrob Agents Chemother (Bethesda). 1965;5:267-72 - PubMed
  37. Pediatrics. 1970 May;45(5):827-38 - PubMed
  38. Antibiot Annu. 1957-1958;5:996-1003 - PubMed
  39. J Am Pharm Assoc Am Pharm Assoc. 1959 Nov;48:623-8 - PubMed
  40. Pediatrics. 1971 Sep;48(3):417-22 - PubMed
  41. J Am Med Assoc. 1953 Mar 7;151(10):805-10 - PubMed
  42. Antibiot Chemother (Northfield). 1962 Jun;12:398-403 - PubMed
  43. Can Med Assoc J. 1975 Jan 25;112(2):170-3 - PubMed
  44. Antibiot Chemother (Northfield). 1953 Oct;3(10):1029-34 - PubMed
  45. Proc Soc Exp Biol Med. 1952 Oct;81(1):175-83 - PubMed
  46. Antibiot Chemother (Northfield). 1953 Jan;3(1):63-6 - PubMed
  47. Am J Med Sci. 1959 Jun;237(6):693-709 - PubMed
  48. Dtsch Med Wochenschr. 1969 Nov 21;94(47):2435-7 - PubMed
  49. Med Welt. 1968 Sep 21;38:2010-9 - PubMed
  50. N Engl J Med. 1973 Jun 7;288(23):1219-21 - PubMed
  51. Can Med Assoc J. 1977 Nov 19;117(10):1159-61 - PubMed
  52. Antibiotic Med Clin Ther (New York). 1958 Oct;5(10):609-13 - PubMed
  53. J Antimicrob Chemother. 1978 Sep;4(5):472-3 - PubMed
  54. Med J Aust. 1971 Dec 18;2(25):1280-3 - PubMed
  55. Antibiotic Med Clin Ther (New York). 1960 Apr;7:231-4 - PubMed
  56. Scand J Infect Dis Suppl. 1978;(14):145-50 - PubMed
  57. Med Clin North Am. 1970 Sep;54(5):1199-215 - PubMed
  58. Antimicrob Agents Chemother (Bethesda). 1966;6:393-6 - PubMed
  59. N Engl J Med. 1959 Feb 26;260(9):408-12 - PubMed
  60. J Am Med Assoc. 1957 Jul 13;164(11):1197-204 - PubMed
  61. JAMA. 1961 Mar 11;175:886-97 - PubMed
  62. Annu Rev Pharmacol. 1965;5:429-46 - PubMed
  63. Med J Aust. 1978 Jul 29;2(3):121-3 - PubMed
  64. Pharmacol Ther Dent. 1970 Oct;1(1):46-55 - PubMed
  65. Antibiot Annu. 1956-1957;:152-8 - PubMed
  66. Antimicrob Agents Chemother (Bethesda). 1965;5:201-5 - PubMed
  67. Antimicrob Agents Chemother. 1976 Feb;9(2):274-87 - PubMed
  68. Am J Med Sci. 1967 Jun;253(6):639-50 - PubMed
  69. Antibiot Chemother (Northfield). 1953 Sep;3(9):920-4 - PubMed
  70. Br Med J. 1974 Jan 26;1(5899):134-7 - PubMed
  71. Antibiot Annu. 1958-1959;6:364-74 - PubMed
  72. Infection. 1977;5(3):183-7 - PubMed
  73. Scand J Infect Dis Suppl. 1978;(14):262-6 - PubMed
  74. J Urol. 1968 Jul;100(1):72-6 - PubMed
  75. Postgrad Med J. 1977 Apr;53(618):195-200 - PubMed
  76. G Ital Chemioter. 1956 Jan-Jun;3(1-2):36-41 - PubMed
  77. JAMA. 1964 Oct 5;190:70-1 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources